MagForce AG
OTC: MGFRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Benjamin J. Lipps
- Employees
- 33
- Headquarters
- Berlin, Germany
- IPO year
- 2018
- Market cap
- $12.0K
- Website
- https://www.magforce.com
Loading MGFRF…
Loading profile data…Frequently asked questions about MGFRF
What does MagForce AG (MGFRF) do?
MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoAc...
Where does MGFRF trade?
MagForce AG (MGFRF) trades on the Other OTC.
What sector is MGFRF in?
MagForce AG (MGFRF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of MagForce AG?
Benjamin J. Lipps is the chief executive officer of MagForce AG (MGFRF).
Where is MagForce AG headquartered?
MagForce AG is headquartered in Germany.
Does MGFRF pay a dividend?
MagForce AG (MGFRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MGFRF go public?
MagForce AG (MGFRF) completed its initial public offering in 2018.